The free H2xspa ligands [xspa = pspa, Clpspa, tspa or fspa where p = 3-(phenyl), Clp = 3-(2-chlorophenyl), t = 3-(2-thienyl), f = 3-(2-furyl) and spa = 2-sulfanylpropenoato], their Zn(II) complexes of formula [HQ]2[Zn(xspa)2] (HQ = diisopropylammonium) and the Cd(II) equivalents were prepared and characterized by elemental analysis and by IR, Raman and NMR (1H, 13C) spectroscopy. X-Ray studies of the crystal structures of [HQ]2[Zn(pspa)2], [HQ]2[Zn(Clpspa)2], [HQ]2[Zn(tspa)2] and [HQ]2[Zn(fspa)2] show that the zinc atom is coordinated to two O atoms and two S atoms of the ligands in a distorted tetrahedral ZnO2S2 environment. In the structures of [HQ]2[Cd(pspa)2] and [HQ]2[Cd(Clpspa)2] the cadmium atom is coordinated to three S atoms and two carboxylato O atoms of the ligands in a distorted trigonal bipyramidal environment. The interchange of ligands between Zn(II) and Cd(II) was studied by 113Cd NMR spectroscopy. The in vitro protective effect of H2xspa and their Zn(II) complexes against Cd toxicity was investigated using the human hepatocarcinoma HepG2 cell line and the pig renal proximal tubule LLC-PK1 cell line. The incorporation of Zn(II) was found to be relevant in the case of H2pspa, with an increase observed in the cell viability of the LCC-PK1 cells with respect to the value for the free ligand.
游离 H2xspa
配体 [xspa = pspa、Clpspa、tspa 或 fspa,其中 p = 3-(苯基)、Clp = 3-(2-
氯苯基)、t = 3-(2-
噻吩基)、f = 3-(2-
呋喃基) 和 spa = 2-
硫烷基
丙烯酸],它们的 Zn(II) 络合物,结构式为 [HQ]2[Zn(xspa)2] (HQ =
二异丙基铵) 和 Cd(II) 等价物的制备和表征通过元素分析以及红外、拉曼和核磁共振 (1H, 13C) 光谱进行。 [HQ]2[Zn(pspa)2]、[HQ]2[Zn(Clpspa)2]、[HQ]2[Zn(tspa)2] 和 [HQ]2[ 晶体结构的 X 射线研究Zn(fspa)2]表明,在扭曲的四面体ZnO2S2环境中,
锌原子与
配体的两个O原子和两个S原子配位。在[HQ]2[Cd(pspa)2]和[HQ]2[Cd(Clpspa)2]的结构中,
镉原子在扭曲的三角双锥环境中与
配体的三个S原子和两个羧基O原子配位。通过 113Cd NMR 光谱研究了 Zn(II) 和 Cd(II) 之间的
配体互换。使用人肝癌 HepG2
细胞系和猪肾近曲小管 LLC-PK1
细胞系研究了 H2xspa 及其 Zn(II) 复合物对 Cd 毒性的体外保护作用。发现 Zn(II) 的掺入与 H2pspa 的情况相关,相对于游离
配体的值,LCC-PK1 细胞的细胞活力有所增加。